Thought emerges and is controlled in the brain via the rhythmically and spatially coordinated activity of millions of neurons, scientists argue in a new article. Understanding cognition and its disorders requires studying it at that level.

Alana Down Syndrome Center team recruiting volunteers to test whether 40Hz light and sound stimulation produces cognitive benefits.

Scientists have now observed how the brain’s place cells stave off inhibitory input in the process of establishing their tuning to specific locations. The study shows that signaling by endocannabinoids is required.

Single-cell gene expression patterns in the brain’s motor and frontal cortex, and evidence from follow-up experiments, reveal many shared cellular and molecular similarities that could be targeted for potential treatment

To learn how the brain works, Picower Institute labs are advancing technologies and methods to watch it live as it happens

Stimulating gamma brain waves may protect cancer patients from memory impairment and other cognitive effects of chemotherapy, a new mouse study suggests.

Stimulating a key brain rhythm with light and sound increases peptide release from interneurons, driving clearance of Alzheimer’s protein via the brain’s glymphatic system, new study suggests.

Across mammalian species, brain waves are slower in deep cortical layers, while superficial layers generate faster rhythms.

At MIT’s Quantitative Methods Workshop, more than 80 students and faculty from a dozen partner institutions became immersed at the intersection of computation and life sciences and forged new ties to MIT and each other.

Assistant Professor Linlin Fan launches a lab to shine a finely focused, innovative spotlight on the neural basis of encoding knowledge.

A new review surveys a broadening landscape of studies showing what’s known, and what remains to be found, about the therapeutic potential of non-invasive sensory, electrical or magnetic stimulation of gamma brain rhythms.

In mice and human cell cultures, MIT researchers showed that novel nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s disease